First author | % of DM | Age | Protocol | Results | |||
---|---|---|---|---|---|---|---|
 |  |  |  | ST resolution | LV function | Enzyme release | Infarct size |
Ischemic PostC | |||||||
Staat | 20 vs. 13 | 58 vs. 56 | 4x 60sR/I | Improved | N/A | Reduced (peak, AUC) | N/A |
Laskey | N/A | 58 vs. 58 | 2x 90sR/I | Improved | N/A | Nochange (peak) | N/A |
Ma | 38 vs. 45 | 64 vs. 64 | 3x 30sR/I | N/A | Improved WMSI | Reduced (peak) | N/A |
Yang | 26 vs. 28 | 59 vs. 63 | 3x 30sR/I | No change | No change | Reduced (AUC) | Reduced (SPECT, 1w) |
Thibault | 12 vs. 10 | 56 vs. 56 | 4x 60sR/I | N/A | Improved EF, WMSI | Reduced (AUC) | Reduced (SPECT, 6m) |
Laskey | 38 vs. 42 | 60 vs. 58 | 2x 90sR/I | Improved | No change | Reduced (peak) | N/A |
Xue | 21 vs. 29 | 54 vs. 62 | 4x 60sR/I | Improved | Improved EF, WMSI | Reduced (peak, AUC) | Reduced (SPECT, 1w) |
Lønborg | 7 vs. 7 | 61 vs. 62 | 4x 30sR/I | No change | No change | N/A | Reduced (CMR, 3m) |
Sörensson | 25 vs. 17 | 63 vs. 62 | 4x 60sR/I | N/A | No change *1 | No change (AUC) | No change (CMR, 1w) *1 |
Freixa | 23 vs. 17 | 59 vs. 60 | 4x 60sR/I | N/A | No change | No change (peak) | No change (CMR, 1w & 6m) |
Tarantini | 18 vs. 3 | 60 vs. 60 | 4x 60sR/I | No change | No change | No change (AUC) | No change (CMR, 1m) |